Manufacturer:

Astrazeneca

Name:

IMJUDO

HCPCS Code Descriptor:

Injection, tremelimumab-actl, 1 mg

Category:

C Code

HCPCS:

C9147

NDC(s):

00310-4505-25, 00310-4535-30,

Primary Type:

Oncology

Route of Administration:

Intravenous

About:

IMJUDO is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The C Code: C9147 is aligned to the drug IMJUDO.

Patient Assistance: